SSEM  >> Vol. 3 No. 4B (August 2014)

    泰州市中小型医药企业发展中的问题及对策
    Problems and Countermeasures in the Development of Taizhou Small and Medium-Sized Pharmaceutical Enterprises

  • 全文下载: PDF(390KB) HTML    PP.16-23   DOI: 10.12677/SSEM.2014.34B003  
  • 下载量: 2,257  浏览量: 6,708  

作者:  

乔莹莹,孟庆军,彭 怡:河海大学商学院,南京

关键词:
医药企业自主创新品牌集群SWOT分析法Pharmaceutical Companies Independent Innovation Brand Cluster SWOT Analysis Method

摘要:

中小型医药企业是推动泰州市经济发展重要力量。随着人口增长,居民收入水平提升,医药企业有了发展机遇。由于原材料、工资、知识产权纠纷与融资成本上升,许多中小型医药企业经营陷入困境。对此,企业需加强与金融机构合作,加强品牌建设,加强自主创新,利用产业集群资源等措施。政府需改善服务水平,在知识产权保护与财税政策等方面支持企业发展。

Small and medium sized pharmaceutical enterprises are an important force of promoting Taizhou economic development. With the population growth and the increase of income levels, pharmaceutical enterprises gain new development opportunities. However, many small and medium sized pharmaceutical enterprises get into trouble because the costs of raw materials, wages, intellectual property disputes and financing have risen. Therefore, these enterprises need to strengthen the cooperation with financial institutions, strengthen the brand building, strengthen the independent innovation and use industrial cluster resources and other measures. Government needs to improve the level of service and support business development in aspects of the intellectual property protection and taxation policies.



文章引用:
乔莹莹, 孟庆军, 彭怡. 泰州市中小型医药企业发展中的问题及对策[J]. 服务科学和管理, 2014, 3(4): 16-23. http://dx.doi.org/10.12677/SSEM.2014.34B003